AAO-HNS COVID-19 Information

The Academy is continuously monitoring the public health situation related to coronavirus disease 2019 (COVID-19) to provide information and resources for you, your practice, and your patients.

Updated April 14, 2021

Part One: Contains comprehensive general considerations that are applicable to all practice settings and specialty areas of otolaryngologists’ practice, including testing guidelines from the Infectious Diseases Society of America.

Part Two: Contains specific recommendations encompassing prioritization and special circumstances related to surgical procedures for all specialty areas.


COVID-19 information for patients can be found on ENThealth.org.


COVID-19 Anosmia Reporting Tool

Latest COVID-19 Updates

Submit site search

Featured Videos

Spencer C. Payne, MD, an otolaryngologist or ear, nose, and throat physician, provides an overview of proper testing technique for COVID-19. Learn more at https://www.enthealth.org

On behalf of the entire Academy, thank you for the leadership, care, and courage you have provided to your patients and the specialty this year. This video expresses our gratitude and was featured during the AAO-HNSF 2020 Virtual Annual Meeting & OTO Experience Opening Ceremony with photos submitted by our members. YOU are our heroes. We wish you the best in 2021.

Gavin Setzen, MD, is joined by Albert L. Merati, MD, Sujana S. Chandrasekhar, MD,  Cherie-Ann Nathan, MD, Joseph K. Han, MD, and Margo K. McKenna, MD,  to discuss the release of Part 2 of the Academy’s Guidance for Return to Practice developed in collaboration with our subspecialty society partners.

No External Use or Transfer (Including AI-Based Technologies): The materials and content on this website are provided for personal, non-commercial transitory viewing only. You are prohibited from copying or transferring any materials or content accessed through this website into applications, software, bots, or websites which may allow third parties to retain or use the content, including but not limited to those using artificial intelligence-based technologies or infrastructure. Please see the Terms of Use for more information.